Feedback / Questions
dabigatran etexilate mesylate oral suspension (WD-1602) - Shanghai Fudan-Zhangjiang, China NT Pharma
https://www.business-standard.com/markets/capital-market-news/alembic-pharma-receives-usfda-approval-for-dabigatran-etexilate-capsules-124081300619_1.html
Aug 13, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next